Down regulation of fatty acid synthase via inhibition of PI3K/AKT/mTOR in ovarian cancer cell line by novel organoselenium pseudopeptide
Open Access
- 19 October 2022
- journal article
- research article
- Published by Elsevier in Current Research in Pharmacology and Drug Discovery
- Vol. 3, 100134
Abstract
No abstract availableKeywords
Funding Information
- Academy of Scientific Research and Technology
This publication has 67 references indexed in Scilit:
- Fatty Acid Synthase As a Potential Therapeutic Target in CancerFuture Oncology, 2010
- In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitorsOncology Reports, 2010
- Reactive oxygen species in cancerFree Radical Research, 2010
- Selenocystine induces reactive oxygen species–mediated apoptosis in human cancer cellsBiomedicine & Pharmacotherapy, 2009
- Cytoplasmic Sequestration of p27 via AKT Phosphorylation in Renal Cell CarcinomaClinical Cancer Research, 2008
- Risk Factors for Ovarian Cancer: An Overview with Emphasis on Hormonal FactorsJournal of Toxicology and Environmental Health, Part B, 2008
- Clonogenic assay of cells in vitroNature Protocols, 2006
- Fatty Acid Synthase and Cancer: New Application of an Old PathwayCancer Research, 2006
- Cancer chemoprevention: Selenium as a prooxidant, not an antioxidantMedical Hypotheses, 2006
- Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cellsOncogene, 2005